Header Logo

Connection

Ozer Algan to Bevacizumab

Back to Details
This is a "connection" page, showing publications Ozer Algan has written about Bevacizumab.
Ozer Algan
Connection Strength
0.051
Bevacizumab
  1. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma. J Clin Oncol. 2023 02 20; 41(6):1285-1295.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.